Login / Signup

Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.

MinKe HeQing LiJingXian ShenGuoSheng TanQiJiong LiJiaYing LaiWei WeiYaoJun ZhangRuHai ZouMinShan ChenRongPing GuoMing Shi
Published in: Cancer medicine (2019)
Triple-drug TACE seems to benefit patients with HCC larger than 10 cm in particular compared with single-drug TACE.
Keyphrases
  • drug induced
  • liver metastases
  • squamous cell carcinoma
  • radiation therapy
  • locally advanced
  • rectal cancer